{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:23:44Z","timestamp":1792797824252,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>\n                    <jats:italic>Abstract<\/jats:italic>\n                  <\/jats:title>\n                  <jats:p>Nuclear factor e2\u2013related factor 2 (Nrf2) plays a key role in cellular resistance to oxidative stress injury. Oxidative stress injury, caused by Nrf2 imbalance, results in increased pyroptosis, DNA damage, and inflammatory activation, which may lead to the arrest of alveolar development and bronchopulmonary dysplasia (BPD) in premature infants under hyperoxic conditions. We established a BPD mouse model to investigate the effects of tert-butylhydroquinone (TBHQ), an Nrf2 activator, on oxidative stress injury, pyroptosis, NLRP3 inflammasome activation, and alveolar development. TBHQ reduced abnormal cell death in the lung tissue of BPD mice and restored the number and normal structure of the alveoli. TBHQ administration activated the Nrf2\/heme oxygenase-1 (HO-1) signaling pathway, resulting in the decrease in the following: reactive oxygen species (ROS), activation of the NOD-like receptor pyrin domain containing 3 (NLRP3) inflammasome, and IL-18 and IL-1\u03b2 expression and activation, as well as inhibition of pyroptosis. In contrast, after Nrf2 gene knockout in BPD mice, there was more severe oxidative stress injury and cell death in the lungs, there were TUNEL\u2009+\u2009and NLRP3\u2009+\u2009co-positive cells in the alveoli, the pyroptosis was significantly increased, and the development of alveoli was significantly blocked. We demonstrated that TBHQ may promote alveolar development by enhancing Nrf2-induced antioxidation in the lung tissue of BPD mice and that the decrease in the NLRP3 inflammasome and pyroptosis caused by Nrf2 activation may be the underlying mechanism. These results suggest that TBHQ is a promising treatment for lung injury in premature infants with hyperoxia.<\/jats:p>","DOI":"10.1007\/s10753-023-01885-4","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T10:02:26Z","timestamp":1691575346000},"page":"2386-2401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Regulating NLRP3 Inflammasome\u2013Induced Pyroptosis via Nrf2: TBHQ Limits Hyperoxia-Induced Lung Injury in a Mouse Model of Bronchopulmonary Dysplasia"],"prefix":"10.1007","volume":"46","author":[{"given":"Minrong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"issue":"1","key":"1885_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12967-018-1417-7","volume":"16","author":"N Principi","year":"2018","unstructured":"Principi, N., G.M. Di Pietro, and S. Esposito. 2018. Bronchopulmonary dysplasia: Clinical aspects and preventive and therapeutic strategies. Journal of Translational Medicine 16 (1): 36. https:\/\/doi.org\/10.1186\/s12967-018-1417-7. (PubMed: 29463286, PubMedCentral: PMC5819643).","journal-title":"Journal of Translational Medicine"},{"key":"1885_CR2","doi-asserted-by":"publisher","unstructured":"Bhattacharya, S., J.A. Mereness, A.M. Baran, R.S. Misra, D.R. Peterson, R.M. Ryan,\u00a0et al. 2021. Lymphocyte-specific biomarkers associated with preterm birth and bronchopulmonary dysplasia. Frontiers in Immunology\u00a011: 563473. https:\/\/doi.org\/10.3389\/fimmu.2020.563473. (PubMed: 33552042, PubMedCentral: PMC7859626).","DOI":"10.3389\/fimmu.2020.563473"},{"issue":"8","key":"1885_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/17476348.2019.1637738","volume":"13","author":"E Williams","year":"2019","unstructured":"Williams, E., and A. Greenough. 2019. Advances in treating bronchopulmonary dysplasia. Expert Review of Respiratory Medicine 13 (8): 727\u2013735. https:\/\/doi.org\/10.1080\/17476348.2019.1637738. (PubMed: 31244360).","journal-title":"Expert Review of Respiratory Medicine"},{"issue":"4","key":"1885_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molmed.2009.02.003","volume":"15","author":"JR Bourbon","year":"2009","unstructured":"Bourbon, J.R., O. Boucherat, J. Boczkowski, B. Crestani, and C. Delacourt. 2009. Bronchopulmonary dysplasia and emphysema: In search of common therapeutic targets. Trends in Molecular Medicine 15 (4): 169\u2013179. https:\/\/doi.org\/10.1016\/j.molmed.2009.02.003. (PubMed: 19303361).","journal-title":"Trends in Molecular Medicine"},{"issue":"7","key":"1885_CR5","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1007\/s12098-021-03766-w","volume":"88","author":"VV Shukla","year":"2021","unstructured":"Shukla, V.V., and N. Ambalavanan. 2021. Recent advances in bronchopulmonary dysplasia. Indian Journal of Pediatrics 88 (7): 690\u2013695. https:\/\/doi.org\/10.1007\/s12098-021-03766-w. (PubMed: 34018135).","journal-title":"Indian Journal of Pediatrics"},{"key":"1885_CR6","doi-asserted-by":"publisher","first-page":"7090534","DOI":"10.1155\/2019\/7090534","volume":"2019","author":"Q Liu","year":"2019","unstructured":"Liu, Q., Y. Gao, and X. Ci. 2019. Role of Nrf2 and its activators in respiratory diseases. Oxidative Medicine and Cellular Longevity 2019: 7090534. https:\/\/doi.org\/10.1155\/2019\/7090534. (PubMed: 30728889, PubMedCentral: PMC6341270).","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"26","key":"1885_CR7","doi-asserted-by":"publisher","first-page":"e20433","DOI":"10.1097\/MD.0000000000020433","volume":"99","author":"D Ma","year":"2020","unstructured":"Ma, D., W. Gao, J. Liu, D. Kong, Y. Zhang, and M. Qian. 2020. Mechanism of oxidative stress and Keap-1\/Nrf2 signaling pathway in bronchopulmonary dysplasia. Medicine (Baltimore) 99 (26): e20433. https:\/\/doi.org\/10.1097\/MD.0000000000020433. (PubMed: 32590729, PubMed Central: PMC7328910).","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1885_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.21037\/tp-20-200","volume":"10","author":"M Zhang","year":"2021","unstructured":"Zhang, M., X. Zhang, X. Chu, L. Cheng, and C. Cai. 2021. Long non-coding RNA MALAT1 plays a protective role in bronchopulmonary dysplasia via the inhibition of apoptosis and interaction with the Keap1\/Nrf2 signal pathway. Translational Pediatrics 10 (2): 265\u2013275. https:\/\/doi.org\/10.21037\/tp-20-200. (PubMed: 33708512, PubMed Central: PMC7944181).","journal-title":"Translational Pediatrics"},{"issue":"8","key":"1885_CR9","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/antiox10081236","volume":"10","author":"M Mathias","year":"2021","unstructured":"Mathias, M., J. Taylor, E. Mendralla, and M. Perez. 2021. Neonatal extracellular superoxide dismutase knockout mice increase total superoxide dismutase activity and VEGF expression after chronic hyperoxia. Antioxidants (Basel) 10 (8): 1236. https:\/\/doi.org\/10.3390\/antiox10081236. (PubMed: 34439484, PubMedCentral: PMC8388997).","journal-title":"Antioxidants (Basel)"},{"key":"1885_CR10","doi-asserted-by":"publisher","first-page":"9912436","DOI":"10.1155\/2021\/9912436","volume":"2021","author":"GE Villalpando-Rodriguez","year":"2021","unstructured":"Villalpando-Rodriguez, G.E., and S.B. Gibson. 2021. Reactive oxygen species (ROS) regulates different types of cell death by acting as a rheostat. Oxidative Medicine and Cellular Longevity 2021: 9912436. https:\/\/doi.org\/10.1155\/2021\/9912436. (PubMed: 34426760, PubMedCentral: PMC8380163).","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"5","key":"1885_CR11","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1183\/09031936.00185511","volume":"40","author":"M Filippone","year":"2012","unstructured":"Filippone, M., G. Bonetto, M. Corradi, A.C. Frigo, and E. Baraldi. 2012. Evidence of unexpected oxidative stress in airways of adolescents born very pre-term. The European Respiratory Journal 40 (5): 1253\u20131259. https:\/\/doi.org\/10.1183\/09031936.00185511. (PubMed: 22408207).","journal-title":"The European Respiratory Journal"},{"issue":"1","key":"1885_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12890-017-0524-1","volume":"17","author":"C Cai","year":"2017","unstructured":"Cai, C., J. Qiu, G. Qiu, Y. Chen, Z. Song, J. Li, et al. 2017. Long non-coding RNA MALAT1 protects preterm infants with bronchopulmonary dysplasia by inhibiting cell apoptosis. BMC Pulmonary Medicine 17 (1): 199. https:\/\/doi.org\/10.1186\/s12890-017-0524-1. (PubMed: 29237426, PubMedCentral: PMC5729463).","journal-title":"BMC Pulmonary Medicine"},{"issue":"4","key":"1885_CR13","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bbagen.2014.11.021","volume":"1850","author":"S Kovac","year":"2015","unstructured":"Kovac, S., P.R. Angelova, K.M. Holmstr\u00f6m, Y. Zhang, A.T. Dinkova-Kostova, and A.Y. Abramov. 2015. Nrf2 regulates ROS production by mitochondria and NADPH oxidase. Biochimica et Biophysica Acta 1850 (4): 794\u2013801. https:\/\/doi.org\/10.1016\/j.bbagen.2014.11.021. (PubMed: 25484314, PubMedCentral: PMC4471129).","journal-title":"Biochimica et Biophysica Acta"},{"issue":"8","key":"1885_CR14","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1089\/ars.2011.4288","volume":"17","author":"HY Cho","year":"2012","unstructured":"Cho, H.Y., B. van Houten, X. Wang, L. Miller-DeGraff, J. Fostel, W. Gladwell, L. Perrow, V. Panduri, L. Kobzik, M. Yamamoto, D.A. Bell, and S.R. Kleeberger. 2012. Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice. Antioxidants and Redox Signaling 17 (8): 1066\u20131082. https:\/\/doi.org\/10.1089\/ars.2011.4288. (PubMed: 22400915, PubMedCentral: PMC3423869).","journal-title":"Antioxidants and Redox Signaling"},{"issue":"1","key":"1885_CR15","doi-asserted-by":"publisher","first-page":"19034","DOI":"10.1038\/s41598-020-75834-8","volume":"10","author":"CM Tamatam","year":"2020","unstructured":"Tamatam, C.M., N.M. Reddy, H.R. Potteti, A. Ankireddy, P.M. Noone, M. Yamamoto, T.W. Kensler, and S.P. Reddy. 2020. Preconditioning the immature lung with enhanced Nrf2 activity protects against oxidant-induced hypoalveolarization in mice. Scientific Reports 10 (1): 19034. https:\/\/doi.org\/10.1038\/s41598-020-75834-8. (PubMed: 33149211, PubMedCentral: PMC7642393).","journal-title":"Scientific Reports"},{"issue":"4","key":"1885_CR16","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3892\/etm.2022.11569","volume":"24","author":"Y Xue","year":"2022","unstructured":"Xue, Y., Y. Zhang, L. Chen, Y. Wang, Z. Lv, L.Q. Yang, and S. Li. 2022. Citrulline protects against LPS-induced acute lung injury by inhibiting ROS\/NLRP3-dependent pyroptosis and apoptosis via the Nrf2 signaling pathway. Experimental and Therapeutic Medicine 24 (4): 632. https:\/\/doi.org\/10.3892\/etm.2022.11569. (PubMed: 36160882, PubMedCentral: PMC9468793).","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"8","key":"1885_CR17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan, M.S.J., E.J. Olhava, W.R. Roush, H.M. Seidel, G.D. Glick, and E. Latz. 2018. Targeting the NLRP3 inflammasome in inflammatory diseases. Nature Reviews. Drug Discovery 17 (8): 588\u2013606. https:\/\/doi.org\/10.1038\/nrd.2018.97. (PubMed: 30026524).","journal-title":"Nature Reviews. Drug Discovery"},{"key":"1885_CR18","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2015.00262","volume":"6","author":"BZ Shao","year":"2015","unstructured":"Shao, B.Z., Z.Q. Xu, B.Z. Han, D.F. Su, and C. Liu. 2015. NLRP3 inflammasome and its inhibitors: A review. Frontiers in Pharmacology 6: 262. https:\/\/doi.org\/10.3389\/fphar.2015.00262. (PubMed: 26594174, PubMedCentral: PMC4633676).","journal-title":"Frontiers in Pharmacology"},{"issue":"8","key":"1885_CR19","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41419-019-1761-4","volume":"10","author":"L Sun","year":"2019","unstructured":"Sun, L., W. Ma, W. Gao, Y. Xing, L. Chen, Z. Xia, Z. Zhang, and Z. Dai. 2019. Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome. Cell Death and Disease 10 (8): 542. https:\/\/doi.org\/10.1038\/s41419-019-1761-4. (PubMed: 31316052, PubMedCentral: PMC6637184).","journal-title":"Cell Death and Disease"},{"issue":"23","key":"1885_CR20","doi-asserted-by":"publisher","first-page":"e146852","DOI":"10.1172\/jci.insight.146852","volume":"6","author":"S Liu","year":"2021","unstructured":"Liu, S., Y. Sun, M. Song, Y. Song, Y. Fang, Q. Zhang, X. Li, N. Song, J. Ding, M. Lu, and G. Hu. 2021. NLRP3\/caspase-1\/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression. JCI Insight 6 (23): e146852. https:\/\/doi.org\/10.1172\/jci.insight.146852. (PubMed: 34877938, PubMedCentral: PMC8675200).","journal-title":"JCI Insight"},{"issue":"3","key":"1885_CR21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1165\/rcmb.2018-0192OC","volume":"61","author":"F Dapaah-Siakwan","year":"2019","unstructured":"Dapaah-Siakwan, F., R. Zambrano, S. Luo, M.R. Duncan, N. Kerr, K. Donda, J.P. de Rivero Vaccari, R.W. Keane, W.D. Dietrich, M. Benny, K. Young, and S. Wu. 2019. Caspase-1 inhibition attenuates hyperoxia-induced lung and brain injury in neonatal mice. American Journal of Respiratory Cell and Molecular Biology 61 (3): 341\u2013354. https:\/\/doi.org\/10.1165\/rcmb.2018-0192OC.","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"1885_CR22","doi-asserted-by":"publisher","first-page":"8977","DOI":"10.1038\/ncomms9977","volume":"6","author":"J Liao","year":"2015","unstructured":"Liao, J., V.S. Kapadia, L.S. Brown, N. Cheong, C. Longoria, D. Mija, M. Ramgopal, J. Mirpuri, D.C. McCurnin, and R.C. Savani. 2015. The NLRP3 inflammasome is critically involved in the development of bronchopulmonary dysplasia. Nature Communications 6: 8977. https:\/\/doi.org\/10.1038\/ncomms9977. (PubMed: 26611836, PubMedCentral: PMC6215764).","journal-title":"Nature Communications"},{"issue":"1","key":"1885_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00395-022-00948-1","volume":"117","author":"X Liu","year":"2022","unstructured":"Liu, X., M. Li, Z. Chen, Y. Yu, H. Shi, Y. Yu, Y. Wang, R. Chen, and J. Ge. 2022. Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis. Basic Research in Cardiology 117 (1): 40. https:\/\/doi.org\/10.1007\/s00395-022-00948-1.","journal-title":"Basic Research in Cardiology"},{"key":"1885_CR24","doi-asserted-by":"publisher","unstructured":"Zhang, J., L. Liu, Y. Zhang, Y. Yuan, Z. Miao, K. Lu, X. Zhang, R. Ni, H. Zhang, Y. Zhao, and\u00a0 X. Wang. 2022. ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation. Redox Biology 58: 102554. https:\/\/doi.org\/10.1016\/j.redox.2022.102554. (PubMed: 36446229, PubMedCentral: PMC9703827).","DOI":"10.1016\/j.redox.2022.102554"},{"key":"1885_CR25","doi-asserted-by":"publisher","unstructured":"Shi, Y.Y., B. Wei, J. Zhou, Z.L. Yin, F. Zhao, Y.J. Peng, Q.W Yu, X.L. Wang, and Y.J. Chen. 2022. Discovery of 5-(3,4-dihydroxybenzylidene)-1,3-dimethylpyrimidine- 2,4,6(1H,3H,5H)-trione as a novel and effective cardioprotective agent via dual anti-inflammatory and anti-oxidative activities. European Journal of Medicinal Chemistry 244: 114848. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114848. (PubMed: 36274277).","DOI":"10.1016\/j.ejmech.2022.114848"},{"issue":"6","key":"1885_CR26","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.molcel.2014.01.033","volume":"53","author":"SN Zucker","year":"2014","unstructured":"Zucker, S.N., E.E. Fink, A. Bagati, S. Mannava, A. Bianchi-Smiraglia, P.N. Bogner, J.A. Wawrzyniak, C. Foley, K.I. Leonova, M.J. Grimm, K. Moparthy, Y. Ionov, J. Wang, S. Liu, S. Sexton, E.S. Kandel, A.V. Bakin, Y. Zhang, N. Kaminski, and M.A. Nikiforov. 2014. Nrf2 amplifies oxidative stress via induction of Klf9. Molecular Cell 53 (6): 916\u2013928. https:\/\/doi.org\/10.1016\/j.molcel.2014.01.033.","journal-title":"Molecular Cell"},{"key":"1885_CR27","doi-asserted-by":"publisher","unstructured":"Tao, W., Y. Hu, Z. Chen, Y. Dai, Y. Hu, and M. Qi. 2021. Magnolol attenuates depressive-like behaviors by polarizing microglia towards the M2 phenotype through the regulation of Nrf2\/HO-1\/NLRP3 signaling pathway. Phytomedicine 91: 153692. https:\/\/doi.org\/10.1016\/j.phymed.2021.153692. (PubMed: 34411834).","DOI":"10.1016\/j.phymed.2021.153692"},{"issue":"2","key":"1885_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.immuni.2013.08.001","volume":"39","author":"SS Iyer","year":"2013","unstructured":"Iyer, S.S., Q. He, J.R. Janczy, E.I. Elliott, Z. Zhong, A.K. Olivier, J.J. Sadler, V. Knepper-Adrian, R. Han, L. Qiao, S.C. Eisenbarth, W.M. Nauseef, S.L. Cassel, and F.S. Sutterwala. 2013. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39 (2): 311\u2013323. https:\/\/doi.org\/10.1016\/j.immuni.2013.08.001.","journal-title":"Immunity"},{"issue":"2","key":"1885_CR29","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s11948-015-9659-8","volume":"22","author":"HJ Curzer","year":"2016","unstructured":"Curzer, H.J., G. Perry, M.C. Wallace, and D. Perry. 2016. The three Rs of animal research: What they mean for the institutional animal care and use committee and why. Science and Engineering Ethics 22 (2): 549\u2013565. https:\/\/doi.org\/10.1007\/s11948-015-9659-8.","journal-title":"Science and Engineering Ethics"},{"issue":"3","key":"1885_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.30802\/AALAS-JAALAS-19-000081","volume":"59","author":"CA Laferriere","year":"2020","unstructured":"Laferriere, C.A., and D.S. Pang. 2020. Review of intraperitoneal injection of sodium pentobarbital as a method of euthanasia in laboratory rodents. Journal of the American Association for Laboratory Animal Science 59 (3): 254\u2013263. https:\/\/doi.org\/10.30802\/AALAS-JAALAS-19-000081.","journal-title":"Journal of the American Association for Laboratory Animal Science"},{"issue":"4","key":"1885_CR31","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.3928\/19382359-20190325-03","volume":"48","author":"MK Tracy","year":"2019","unstructured":"Tracy, M.K., and S.K. Berkelhamer. 2019. Bronchopulmonary dysplasia and pulmonary outcomes of prematurity. Pediatric Annals 48 (4): e148\u2013e153. https:\/\/doi.org\/10.3928\/19382359-20190325-03. (PubMed: 30986315).","journal-title":"Pediatric Annals"},{"issue":"1","key":"1885_CR32","doi-asserted-by":"publisher","first-page":"e2020030007","DOI":"10.1542\/peds.2020-030007","volume":"148","author":"EA Jensen","year":"2021","unstructured":"Jensen, E.A., E.M. Edwards, L.T. Greenberg, R.F. Soll, D.E.Y. Ehret, and J.D. Horbar. 2021. Severity of bronchopulmonary dysplasia among very preterm infants in the United States. Pediatrics 148 (1): e2020030007. https:\/\/doi.org\/10.1542\/peds.2020-030007. (PubMed: 34078747, PubMedCentral: PMC8290972).","journal-title":"Pediatrics"},{"key":"1885_CR33","doi-asserted-by":"publisher","unstructured":"Jensen, E.A., and B. Schmidt. 2014. Epidemiology of bronchopulmonary dysplasia. Birth Defects Research. Part A, Clinical and Molecular Teratology 100(3): 145\u2013157. https:\/\/doi.org\/10.1002\/bdra.23235. (PubMed: 24639412, PubMedCentral: PMC8604158)","DOI":"10.1002\/bdra.23235"},{"issue":"7","key":"1885_CR34","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1053\/j.semperi.2018.09.013","volume":"42","author":"JLY Cheong","year":"2018","unstructured":"Cheong, J.L.Y., and L.W. Doyle. 2018. An update on pulmonary and neurodevelopmental outcomes of bronchopulmonary dysplasia. Seminars in Perinatology 42 (7): 478\u2013484. https:\/\/doi.org\/10.1053\/j.semperi.2018.09.013. (PubMed: 30401478).","journal-title":"Seminars in Perinatology"},{"issue":"2","key":"1885_CR35","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/pan.14365","volume":"32","author":"AR Schmidt","year":"2022","unstructured":"Schmidt, A.R., and C. Ramamoorthy. 2022. Bronchopulmonary dysplasia. Paediatric Anaesthesia 32 (2): 174\u2013180. https:\/\/doi.org\/10.1111\/pan.14365. (PubMed: 34877749).","journal-title":"Paediatric Anaesthesia"},{"key":"1885_CR36","doi-asserted-by":"publisher","first-page":"9010354","DOI":"10.1155\/2022\/9010354","volume":"2022","author":"W Liu","year":"2022","unstructured":"Liu, W., S. Li, Y. Li, W. Shen, H. Chen, X. Li, et al. 2022. Decreased polymorphonuclear myeloid-derived suppressor cells and ROS production correlated closely with bronchopulmonary dysplasia in preterm infants. Oxidative Medicine and Cellular Longevity 2022: 9010354. https:\/\/doi.org\/10.1155\/2022\/9010354. (PubMed: 36193058, PubMedCentral: PMC9526632).","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"3","key":"1885_CR37","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00441-016-2534-3","volume":"367","author":"C Nardiello","year":"2017","unstructured":"Nardiello, C., I. Mi\u017e\u00edkov\u00e1, and R.E. Morty. 2017. Looking ahead: Where to next for animal models of bronchopulmonary dysplasia? Cell and Tissue Research 367 (3): 457\u2013468. https:\/\/doi.org\/10.1007\/s00441-016-2534-3.","journal-title":"Cell and Tissue Research"},{"issue":"13","key":"1885_CR38","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.3390\/ijms21134777","volume":"21","author":"F He","year":"2020","unstructured":"He, F., X. Ru, and T. Wen. 2020. NRF2, a transcription factor for stress response and beyond. International Journal of Molecular Sciences 21 (13): 4777. https:\/\/doi.org\/10.3390\/ijms21134777. (PubMed: 32640524, PubMedCentral: PMC7369905).","journal-title":"International Journal of Molecular Sciences"},{"issue":"17","key":"1885_CR39","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342.PubMed:28899199,PubMedCentral:PMC6208165","volume":"29","author":"C Tonelli","year":"2018","unstructured":"Tonelli, C., I.I.C. Chio, and D.A. Tuveson. 2018. Transcriptional regulation by Nrf2. Antioxidants and Redox Signaling 29 (17): 1727\u20131745. https:\/\/doi.org\/10.1089\/ars.2017.7342.PubMed:28899199,PubMedCentral:PMC6208165.","journal-title":"Antioxidants and Redox Signaling"},{"key":"1885_CR40","doi-asserted-by":"publisher","unstructured":"Zhao, X., Y. Shi, D. Zhang, X. Tong, Y. Sun, X. Xue, et al. 2020. Autophagy inducer activates Nrf2-ARE pathway to attenuate aberrant alveolarization in neonatal mice with bronchopulmonary dysplasia. Life Sciences 252: 117662. https:\/\/doi.org\/10.1016\/j.lfs.2020.117662. (PubMed: 32298739).","DOI":"10.1016\/j.lfs.2020.117662"},{"issue":"1","key":"1885_CR41","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.cyto.2013.09.021","volume":"65","author":"SA McGrath-Morrow","year":"2014","unstructured":"McGrath-Morrow, S.A., T. Lauer, J.M. Collaco, A. Lopez, D. Malhotra, Y.O. Alekseyev, et al. 2014. Transcriptional responses of neonatal mouse lung to hyperoxia by Nrf2 status. Cytokine 65 (1): 4\u20139. https:\/\/doi.org\/10.1016\/j.cyto.2013.09.021. (PubMed: 24139870, PubMedCentral: PMC3875154).","journal-title":"Cytokine"},{"issue":"3","key":"1885_CR42","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/nu12030682","volume":"12","author":"J Lorenzon Dos Santos","year":"2020","unstructured":"Lorenzon Dos Santos, J., A.S. de Quadros, C. Weschenfelder, S.B. Garofallo, and A. Marcadenti. 2020. Oxidative stress biomarkers, nut-related antioxidants, and cardiovascular disease. Nutrients 12 (3): 682. https:\/\/doi.org\/10.3390\/nu12030682. (PubMed: 32138220, PubMedCentral: PMC7146201).","journal-title":"Nutrients"},{"issue":"1","key":"1885_CR43","doi-asserted-by":"publisher","first-page":"64","DOI":"10.23736\/S0375-9393.19.13906-5","volume":"86","author":"S Ottolenghi","year":"2020","unstructured":"Ottolenghi, S., G. Sabbatini, A. Brizzolari, M. Samaja, and D. Chiumello. 2020. Hyperoxia and oxidative stress in anesthesia and critical care medicine. Minerva Anestesiologica 86 (1): 64\u201375. https:\/\/doi.org\/10.23736\/S0375-9393.19.13906-5. (PubMed: 31680497).","journal-title":"Minerva Anestesiologica"},{"key":"1885_CR44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.freeradbiomed.2019.03.035","volume":"142","author":"M Perez","year":"2019","unstructured":"Perez, M., M.E. Robbins, C. Revhaug, and O.D. Saugstad. 2019. Oxygen radical disease in the newborn, revisited: Oxidative stress and disease in the newborn period. Free Radical Biology and Medicine 142: 61\u201372. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.03.035. (PubMed: 30954546, PubMedCentral: PMC6791125).","journal-title":"Free Radical Biology and Medicine"},{"key":"1885_CR45","doi-asserted-by":"publisher","unstructured":"Tastan, B., B.I. Arioz, and S. Genc. 2022. Targeting NLRP3 inflammasome with Nrf2 inducers in central nervous system disorders. Frontiers in Immunology 13: 865772. https:\/\/doi.org\/10.3389\/fimmu.2022.865772. (PubMed: 35418995, PubMedCentral: PMC8995746).","DOI":"10.3389\/fimmu.2022.865772"},{"key":"1885_CR46","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.freeradbiomed.2021.10.007","volume":"176","author":"R Dhar","year":"2021","unstructured":"Dhar, R., M.N. Rana, L. Zhang, Y. Li, N. Li, Z. Hu, et al. 2021. Phosphodiesterase 4B is required for NLRP3 inflammasome activation by positive feedback with Nrf2 in the early phase of LPS-induced acute lung injury. Free Radical Biology and Medicine 176: 378\u2013391. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.10.007. (PubMed: 34644617).","journal-title":"Free Radical Biology and Medicine"},{"issue":"1","key":"1885_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13020-021-00541-z","volume":"16","author":"Y Liu","year":"2021","unstructured":"Liu, Y., J. Zhou, Y. Luo, J. Li, L. Shang, F. Zhou, et al. 2021. Honokiol alleviates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis via Nrf2 activation in vitro and in vivo. Chinese Medicine 16 (1): 127. https:\/\/doi.org\/10.1186\/s13020-021-00541-z. (PubMed: 34844623, PubMedCentral: PMC8628413).","journal-title":"Chinese Medicine"},{"key":"1885_CR48","doi-asserted-by":"publisher","unstructured":"Ruan, H., W. Li, J. Wang, G. Chen, B. Xia, Z. Wang,\u00a0et al. 2020. Propofol alleviates ventilator-induced lung injury through regulating the Nrf2\/NLRP3 signaling pathway. Experimental and Molecular Pathology 114: 104427. https:\/\/doi.org\/10.1016\/j.yexmp.2020.104427. (PubMed: 32199914).","DOI":"10.1016\/j.yexmp.2020.104427"},{"issue":"22","key":"1885_CR49","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","volume":"25","author":"S Saha","year":"2020","unstructured":"Saha, S., B. Buttari, E. Panieri, E. Profumo, and L. Saso. 2020. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules 25 (22): 5474. https:\/\/doi.org\/10.3390\/molecules25225474. (PubMed:33238435, PubMedCentral: 7700122).","journal-title":"Molecules"},{"issue":"1","key":"1885_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13062-022-00351-9,PubMed:36447296,PubMedCentral:PMC9706911","volume":"17","author":"L Xu","year":"2022","unstructured":"Xu, L., Y. Zhu, C. Li, Q. Wang, L. Ma, J. Wang, et al. 2022. Small extracellular vesicles derived from Nrf2-overexpressing human amniotic mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting NLRP3. Biology Direct 17 (1): 35. https:\/\/doi.org\/10.1186\/s13062-022-00351-9,PubMed:36447296,PubMedCentral:PMC9706911.","journal-title":"Biology Direct"},{"key":"1885_CR51","doi-asserted-by":"publisher","unstructured":"Bursley, J. K., and Rockwell, C. E. 2020. Nrf2-dependent and -independent effects of tBHQ in activated murine B cells. Food and Chemical Toxicology 145: 111595. https:\/\/doi.org\/10.1016\/j.fct.2020.111595. (PubMed: 32702509, PubMedCentral: PMC7568862).","DOI":"10.1016\/j.fct.2020.111595"},{"key":"1885_CR52","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.fct.2018.08.067","volume":"121","author":"AP Boss","year":"2018","unstructured":"Boss, A.P., R.A. Freeborn, D.M. Duriancik, R.C. Kennedy, E.M. Gardner, and C.E. Rockwell. 2018. The Nrf2 activator tBHQ inhibits the activation of primary murine natural killer cells. Food and Chemical Toxicology 121: 231\u2013236. https:\/\/doi.org\/10.1016\/j.fct.2018.08.067. (PubMed: 30171972, PubMedCentral: PMC6287942).","journal-title":"Food and Chemical Toxicology"},{"issue":"5","key":"1885_CR53","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1007\/s11064-011-0417-2","volume":"36","author":"F Nouhi","year":"2011","unstructured":"Nouhi, F., S.K. Tusi, A. Abdi, and F. Khodagholi. 2011. Dietary supplementation with tBHQ, an Nrf2 stabilizer molecule, confers neuroprotection against apoptosis in amyloid \u03b2-injected rat. Neurochemical Research 36 (5): 870\u2013878. https:\/\/doi.org\/10.1007\/s11064-011-0417-2. (PubMed: 21293924).","journal-title":"Neurochemical Research"},{"key":"1885_CR54","doi-asserted-by":"publisher","first-page":"4310475","DOI":"10.1155\/2017\/4310475","volume":"2017","author":"Y Wang","year":"2017","unstructured":"Wang, Y., Y.H. Gu, M. Liu, Y. Bai, L.Y. Liang, and H.L. Wang. 2017. TBHQ alleviated endoplasmic reticulum stress-apoptosis and oxidative stress by PERK-Nrf2 crosstalk in methamphetamine-induced chronic pulmonary toxicity. Oxidative Medicine and Cellular Longevity 2017: 4310475. https:\/\/doi.org\/10.1155\/2017\/4310475. (PubMed: 28303170, PubMedCentral: PMC5337881).","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"1885_CR55","doi-asserted-by":"publisher","first-page":"8787156","DOI":"10.1155\/2020\/8787156","volume":"2020","author":"X Meng","year":"2020","unstructured":"Meng, X., C. Zhang, Y. Guo, Y. Han, C. Wang, H. Chu, et al. 2020. TBHQ attenuates neurotoxicity induced by methamphetamine in the VTA through the Nrf2\/HO-1 and PI3K\/AKT signaling pathways. Oxidative Medicine and Cellular Longevity 2020: 8787156. https:\/\/doi.org\/10.1155\/2020\/8787156. (PubMed: 32351675, PubMedCentral: PMC7174937).","journal-title":"Oxidative Medicine and Cellular Longevity"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01885-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-023-01885-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01885-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T03:18:06Z","timestamp":1700795886000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-023-01885-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["1885"],"URL":"https:\/\/doi.org\/10.1007\/s10753-023-01885-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2723273\/v1","asserted-by":"object"}]},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"22 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments complied with the ARRIVE guidelines and were performed according to the UK Animals (Scientific Procedures) Act of 1986 and the National Research Council\u2019s Guide for the Care and Use of Laboratory Animals. This study was approved by the Institutional Animal Ethics Committee (reference number: CHENGYIDONGLUN2021017).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}